Michael J. Bourque bought $25k of INGN
EVP, CFO & Treasurer at Inogen Inc. 3,000 shares at an average of $8.32, traded Mar 3, 2025, filed Mar 4, 2025.
Score components
- +22RoleCFO
- 0Trade size$25k at market
- +3Relative to holdingsHoldings up 7%
- 0Price contextNo price history yet
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
- -1510b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-25-032642, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 1, 2025 | AGrant or award Common Stock10b5-1 | +600 | $8.33 | $4,998 | 600 | Mar 4, 2025 |
| Mar 1, 2025 | MOption exercise Common Stock10b5-1 | +25,000 | $0.00 | $0 | 25,600 | Mar 4, 2025 |
| Mar 1, 2025 | FTax withholding Common Stock10b5-1 | -9,838 | $8.33 | $82k | 15,762 | Mar 4, 2025 |
| Mar 1, 2025 | AGrant or award Common Stock10b5-1 | +47,625 | $0.00 | $0 | 63,387 | Mar 4, 2025 |
| Mar 1, 2025 | FTax withholding Common Stock10b5-1 | -18,741 | $8.33 | $156k | 44,646 | Mar 4, 2025 |
| Mar 3, 2025 | POpen-market purchase Common Stock10b5-1 | +3,000 | $8.32 | $25k | 47,646 | Mar 4, 2025 |
| Feb 28, 2025 | AGrant or award Restricted Stock Unitderivative10b5-1 | +51,020 | $0.00 | $0 | 51,020 | Mar 4, 2025 |
| Mar 1, 2025 | MOption exercise Restricted Stock Unitderivative10b5-1 | -25,000 | $0.00 | $0 | 50,000 | Mar 4, 2025 |
Related signals
Other insiders at Inogen Inc and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 31Weak | Inogen Inc | Kevin Raymond Merrill Smith CEO and President | $100k 11,709 shares | +20% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.